Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4005559 Title: COMPOSITIONS PHARMACEUTIQUES DE L'ACIDE 3- (6- (1- (2,2-DIFLUOROBENZO [D] [1,3] DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO) -3-MÉTHYLPYRIODIN-2-YL) D'ACIDE BENZOÏQUE ET LEUR ADMINISTRATION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
211979711
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
4005559
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
07/04/2011
Grant date:
26/02/2025
EP publication date:
01/06/2022
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/02/2025
EP B1 publication date:
26/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/04/2025
Expiration date (if granted and all annual fees paid):
07/04/2031

Applicant

Name:
Vertex Pharmaceuticals Incorporated
Legal Form:
From:
26/02/2025
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)
To:

Inventor

1

Name:
VERWIJS, Marinus, Jacobus
Legal Form:
Address:
Framingham, 01701, United States (US)

2

Name:
ALARGOVA, Rossitza, Gueorguieva
Legal Form:
Address:
Brighton, 02135, United States (US)

3

Name:
KAUSHIK, Ritu, Rohit
Legal Form:
Address:
Watertown, 02472, United States (US)

4

Name:
KADIYALA, Irina, Nikolaevna
Legal Form:
Address:
Newton, 02457, United States (US)

5

Name:
YOUNG, Christopher, Ryan
Legal Form:
Address:
Waltham, 02451, United States (US)

Priority

1

Priority patent number:
36656210 P
Priority date:
22/07/2010
Priority country:
United States (US)

2

Priority patent number:
32174810 P
Priority date:
07/04/2010
Priority country:
United States (US)

3

Priority patent number:
32172910 P
Priority date:
07/04/2010
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/16; A61K 9/20; A61K 9/28; C07D 213/75; C07D 405/12; C07D 405/14;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2025/04
Publication date:
15/05/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2025/23
Publication date:
30/12/2025
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type